Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A Phase III, Randomized, Double-blinded, Parallel Group, Multi-centre Study to Assess the Efficacy and Safety of ZD6474 (ZACTIMA™) in Combination with Pemetrexed (Alimta®) versus Pemetrexed alone in Patients with Locally-Advanced or Metastatic (stage IIIB or IV) Non-Small Cell Lung Cancer (NSCLC) after Failure of 1st Line Anti-cancer Therapy https://www.kusajili.com:443/Trial/A7KN54o1mES4qGXlXImvog%24a-phase-iii-randomized-double-blinded-parallel-group-multi-centre-study-to-assess-the-efficacy-and-safety-of-zd6474-zactimat-in
I have read and accept the terms of use of the site and the Privacy Policy
Send your message